Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) reported a net loss after zakat and tax of SAR 177.7 million for the first nine months of 2019, against a net profit of SAR 49.8 million a year earlier.
| Item | 9m 2018 | 9m 2019 | Change |
|---|---|---|---|
| Revenues | 902.54 | 1,142.52 | 26.6 % |
| Gross Income | 480.73 | 418.35 | (13.0 %) |
| Operating Income | 69.39 | (1.33) | (101.9 %) |
| Net Income | 57.57 | (180.09) | (412.8 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 0.48 | (1.50) | (412.8 %) |
The losses were attributed to a decline in gross profit and product prices. SPIMACO also adjusted the provision for sales recovery according to IFRS 15 requirements.
SPIMACO posted a net profit after zakat and tax of SAR 30 million, against a net loss of SAR 3.4 million in year-earlier period, driven by higher sales and gross profit, along with improved efficiency of operating expenses.
The company turned profitable in Q3 2019, after incurring net losses of SAR 188.5 million in Q2 2019, thanks to seasonal factors, higher gross profit and improved sales mix.
| Item | Q3 2018 | Q3 2019 | Change |
|---|---|---|---|
| Revenues | 224.95 | 342.69 | 52.3 % |
| Gross Income | 137.89 | 170.82 | 23.9 % |
| Operating Income | 3.59 | 46.71 | 1201.2 % |
| Net Income | (12.12) | 28.11 | 332.0 % |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | (0.10) | 0.23 | 332.0 % |
| Item | Q2 2019 | Q3 2019 | Change |
|---|---|---|---|
| Revenues | 355.03 | 342.69 | (3.5 %) |
| Gross Income | 95.10 | 170.82 | 79.6 % |
| Operating Income | (65.02) | 46.71 | 171.8 % |
| Net Income | (186.49) | 28.11 | 115.1 % |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | (1.55) | 0.23 | 115.1 % |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2010 | 274.33 | 6.4 % | 118.90 | 9.5 % | 45.32 | 6.2 % | 0.38 |
| Q2 2010 | 252.34 | 10.2 % | 100.50 | 23.3 % | 43.09 | 14.0 % | 0.36 |
| Q3 2010 | 191.40 | 11.8 % | 85.88 | 18.5 % | 18.07 | 14.1 % | 0.15 |
| Q4 2010 | 319.57 | 9.2 % | 181.12 | 15.4 % | 70.04 | 19.8 % | 0.58 |
| 2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
| Q1 2011 | 252.08 | (8.1 %) | 123.51 | 3.9 % | 45.71 | 0.9 % | 0.38 |
| Q2 2011 | 292.08 | 15.7 % | 123.61 | 23.0 % | 60.75 | 41.0 % | 0.51 |
| Q3 2011 | 209.24 | 9.3 % | 106.76 | 24.3 % | 29.75 | 64.6 % | 0.25 |
| Q4 2011 | 375.82 | 17.6 % | 206.69 | 14.1 % | 74.06 | 5.7 % | 0.62 |
| 2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
| Q1 2012 | 303.14 | 20.3 % | 153.21 | 24.0 % | 56.45 | 23.5 % | 0.47 |
| Q2 2012 | 286.64 | (1.9 %) | 140.91 | 14.0 % | 90.14 | 48.4 % | 0.75 |
| Q3 2012 | 227.40 | 8.7 % | 113.28 | 6.1 % | 32.33 | 8.7 % | 0.27 |
| Q4 2012 | 365.97 | (2.6 %) | 211.16 | 2.2 % | 53.73 | (27.5 %) | 0.45 |
| 2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
| Q1 2013 | 361.37 | 19.2 % | 184.62 | 20.5 % | 63.15 | 11.9 % | 0.53 |
| Q2 2013 | 344.22 | 20.1 % | 179.12 | 27.1 % | 113.71 | 26.1 % | 0.95 |
| Q3 2013 | 222.91 | (2.0 %) | 118.64 | 4.7 % | 34.19 | 5.8 % | 0.28 |
| Q4 2013 | 382.01 | 4.4 % | 226.14 | 7.1 % | 57.01 | 6.1 % | 0.48 |
| 2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
| Q1 2014 | 405.21 | 12.1 % | 206.72 | 12.0 % | 91.17 | 44.4 % | 0.76 |
| Q2 2014 | 371.14 | 7.8 % | 193.14 | 7.8 % | 97.72 | (14.1 %) | 0.81 |
| Q3 2014 | 266.02 | 19.3 % | 134.45 | 13.3 % | 36.69 | 7.3 % | 0.31 |
| Q4 2014 | 431.06 | 12.8 % | 261.80 | 15.8 % | 91.29 | 60.1 % | 0.76 |
| 2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
| Q1 2015 | 432.20 | 6.7 % | 225.86 | 9.3 % | 99.39 | 9.0 % | 0.83 |
| Q2 2015 | 435.80 | 17.4 % | 210.95 | 9.2 % | 237.63 | 143.2 % | 1.98 |
| Q3 2015 | 308.27 | 15.9 % | 131.32 | (2.3 %) | 29.16 | (20.5 %) | 0.24 |
| Q4 2015 | 520.38 | 20.7 % | 266.38 | 1.7 % | (9.12) | (110.0 %) | (0.08) |
| 2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
| Q1 2016 | 322.20 | (25.4 %) | 194.26 | (14.0 %) | 88.91 | (10.5 %) | 0.74 |
| Q2 2016 | 339.54 | (22.1 %) | 183.58 | (13.0 %) | 39.61 | (83.3 %) | 0.33 |
| Q3 2016 | 257.21 | (16.6 %) | 140.54 | 7.0 % | 4.76 | (83.7 %) | 0.04 |
| Q4 2016 | 339.59 | (34.7 %) | 194.16 | (27.1 %) | 143.48 | 1673.8 % | 1.20 |
| 2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
| Q1 2017 | 393.10 | 22.0 % | 212.58 | 9.4 % | 101.22 | 13.8 % | 0.84 |
| Q2 2017 | 304.63 | (10.3 %) | 156.13 | (15.0 %) | 46.56 | 17.5 % | 0.39 |
| Q3 2017 | 277.62 | 7.9 % | 128.68 | (8.4 %) | (17.03) | (457.9 %) | (0.14) |
| Q4 2017 | 410.69 | 20.9 % | 207.07 | 6.7 % | 66.61 | (53.6 %) | 0.56 |
| 2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 197.37 | (28.7 %) | 1.64 |
| Q1 2018 | 390.79 | (0.6 %) | 197.32 | (7.2 %) | 55.23 | (45.4 %) | 0.46 |
| Q2 2018 | 295.62 | (3.0 %) | 155.28 | (0.5 %) | 22.67 | (51.3 %) | 0.19 |
| Q3 2018 | 224.95 | (19.0 %) | 137.89 | 7.2 % | (12.12) | 28.8 % | (0.10) |
| Q4 2018 | 600.79 | 46.3 % | 127.79 | (38.3 %) | 19.01 | (71.5 %) | 0.16 |
| 2018 | 1,503.32 | 8.5 % | 608.52 | (13.6 %) | 76.58 | (61.2 %) | 0.64 |
| Q1 2019 | 444.80 | 13.8 % | 152.43 | (22.7 %) | (21.71) | (139.3 %) | (0.18) |
| Q2 2019 | 355.03 | 20.1 % | 95.10 | (38.8 %) | (186.49) | (922.8 %) | (1.55) |
| Q3 2019 | 342.69 | 52.3 % | 170.82 | 23.9 % | 28.11 | 332.0 % | 0.23 |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| 2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 154.81 | 20.7 % | 1.53 |
| 2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
| 2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
| 2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
| 2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
| 2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
| 2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
| 2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
| 2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 197.37 | (28.7 %) | 1.64 |
| 2018 | 1,503.32 | 8.5 % | 608.52 | (13.6 %) | 76.58 | (61.2 %) | 0.64 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2010 | 44.45 % | 18.88 % | 16.94 % |
| Q2 2010 | 45.32 % | 18.93 % | 17.07 % |
| Q3 2010 | 45.73 % | 18.73 % | 16.95 % |
| Q4 2010 | 46.88 % | 18.85 % | 17.32 % |
| 2010 | 46.88 % | 18.85 % | 17.32 % |
| Q1 2011 | 48.36 % | 18.99 % | 17.42 % |
| Q2 2011 | 48.73 % | 19.12 % | 18.44 % |
| Q3 2011 | 49.86 % | 19.99 % | 19.22 % |
| Q4 2011 | 49.64 % | 19.57 % | 18.62 % |
| 2011 | 49.64 % | 19.65 % | 18.72 % |
| Q1 2012 | 50.01 % | 19.86 % | 18.73 % |
| Q2 2012 | 51.72 % | 20.36 % | 21.31 % |
| Q3 2012 | 51.47 % | 20.54 % | 21.21 % |
| Q4 2012 | 52.28 % | 19.56 % | 19.66 % |
| 2012 | 52.28 % | 19.56 % | 19.66 % |
| Q1 2013 | 52.36 % | 19.26 % | 19.28 % |
| Q2 2013 | 52.98 % | 18.87 % | 20.24 % |
| Q3 2013 | 53.58 % | 18.66 % | 20.45 % |
| Q4 2013 | 54.06 % | 18.26 % | 20.45 % |
| 2013 | 54.06 % | 18.16 % | 20.36 % |
| Q1 2014 | 53.95 % | 17.92 % | 21.86 % |
| Q2 2014 | 53.91 % | 17.74 % | 20.28 % |
| Q3 2014 | 53.39 % | 16.79 % | 19.84 % |
| Q4 2014 | 54.03 % | 18.15 % | 21.50 % |
| 2014 | 54.04 % | 18.15 % | 21.55 % |
| Q1 2015 | 54.34 % | 18.90 % | 21.67 % |
| Q2 2015 | 53.23 % | 18.31 % | 20.04 % |
| Q3 2015 | 51.63 % | 17.40 % | 19.05 % |
| Q4 2015 | 49.19 % | 17.17 % | 19.11 % |
| 2015 | 49.77 % | 16.85 % | 19.02 % |
| Q1 2016 | 50.60 % | 15.90 % | 18.80 % |
| Q2 2016 | 52.04 % | 15.52 % | 16.88 % |
| Q3 2016 | 54.52 % | 15.09 % | 15.79 % |
| Q4 2016 | 56.62 % | 10.25 % | 5.68 % |
| 2016 | 56.62 % | 10.25 % | 5.68 % |
| Q1 2017 | 54.97 % | 9.67 % | 3.99 % |
| Q2 2017 | 54.34 % | 11.85 % | 4.64 % |
| Q3 2017 | 52.59 % | 11.94 % | 2.91 % |
| Q4 2017 | 50.83 % | 14.96 % | 9.94 % |
| 2017 | 50.83 % | 14.96 % | 9.94 % |
| Q1 2018 | 49.81 % | 16.45 % | 9.97 % |
| Q2 2018 | 50.07 % | 14.49 % | 8.30 % |
| Q3 2018 | 52.76 % | 15.07 % | 9.00 % |
| Q4 2018 | 40.89 % | 5.68 % | 5.61 % |
| 2018 | 40.48 % | 4.92 % | 5.09 % |
| Q1 2019 | 36.61 % | 2.64 % | 0.50 % |
| Q2 2019 | 31.57 % | (2.89 %) | (5.68 %) |
| Q3 2019 | 31.33 % | 0.66 % | (2.99 %) |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| 2009 | 44.13 % | 18.49 % | 16.63 % |
| 2010 | 46.88 % | 18.85 % | 17.32 % |
| 2011 | 49.64 % | 19.65 % | 18.72 % |
| 2012 | 52.28 % | 19.56 % | 19.66 % |
| 2013 | 54.06 % | 18.16 % | 20.36 % |
| 2014 | 54.04 % | 18.15 % | 21.55 % |
| 2015 | 49.77 % | 16.85 % | 19.02 % |
| 2016 | 56.62 % | 10.25 % | 5.68 % |
| 2017 | 50.83 % | 14.96 % | 9.94 % |
| 2018 | 40.48 % | 4.92 % | 5.09 % |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2010 | 43.34 % | 21.92 % | 17.70 % |
| Q2 2010 | 39.83 % | 11.52 % | 17.08 % |
| Q3 2010 | 44.87 % | 14.68 % | 9.44 % |
| Q4 2010 | 56.68 % | 24.50 % | 21.92 % |
| Q1 2011 | 49.00 % | 22.74 % | 18.13 % |
| Q2 2011 | 42.32 % | 13.00 % | 20.80 % |
| Q3 2011 | 51.02 % | 19.57 % | 14.22 % |
| Q4 2011 | 55.00 % | 22.56 % | 19.71 % |
| Q1 2012 | 50.54 % | 23.32 % | 18.62 % |
| Q2 2012 | 49.16 % | 14.95 % | 31.45 % |
| Q3 2012 | 49.82 % | 20.53 % | 14.22 % |
| Q4 2012 | 57.70 % | 19.47 % | 14.68 % |
| Q1 2013 | 51.09 % | 21.68 % | 17.48 % |
| Q2 2013 | 52.04 % | 14.20 % | 33.03 % |
| Q3 2013 | 53.22 % | 19.34 % | 15.34 % |
| Q4 2013 | 59.20 % | 18.05 % | 14.92 % |
| Q1 2014 | 51.02 % | 20.19 % | 22.50 % |
| Q2 2014 | 52.04 % | 13.80 % | 26.33 % |
| Q3 2014 | 50.54 % | 13.97 % | 13.79 % |
| Q4 2014 | 60.73 % | 22.54 % | 21.18 % |
| Q1 2015 | 52.26 % | 22.70 % | 23.00 % |
| Q2 2015 | 48.40 % | 12.42 % | 19.81 % |
| Q3 2015 | 42.60 % | 9.85 % | 9.46 % |
| Q4 2015 | 51.19 % | 20.88 % | 21.02 % |
| Q1 2016 | 60.29 % | 18.36 % | 22.80 % |
| Q2 2016 | 54.07 % | 9.77 % | 11.67 % |
| Q3 2016 | 54.64 % | 6.30 % | 1.85 % |
| Q4 2016 | 57.18 % | 6.04 % | (13.65 %) |
| Q1 2017 | 54.08 % | 14.94 % | 14.01 % |
| Q2 2017 | 51.25 % | 19.02 % | 15.29 % |
| Q3 2017 | 46.35 % | 7.17 % | (6.13 %) |
| Q4 2017 | 50.42 % | 17.25 % | 12.96 % |
| Q1 2018 | 50.49 % | 20.19 % | 14.13 % |
| Q2 2018 | 52.53 % | 9.98 % | 7.67 % |
| Q3 2018 | 61.30 % | 8.88 % | (5.39 %) |
| Q4 2018 | 21.27 % | (7.08 %) | 3.16 % |
| Q1 2019 | 34.27 % | 7.75 % | (4.88 %) |
| Q2 2019 | 26.79 % | (16.60 %) | (21.86 %) |
| Q3 2019 | 49.85 % | 22.90 % | 8.20 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2010 | 120.00 | 1.31 | 1.36 | 22.04 |
| Q2 2010 | 120.00 | 1.36 | 1.41 | 19.98 |
| Q3 2010 | 120.00 | 1.37 | 1.43 | 21.69 |
| Q4 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
| Q1 2011 | 120.00 | 1.47 | 1.47 | 25.41 |
| Q2 2011 | 120.00 | 1.62 | 1.62 | 27.29 |
| Q3 2011 | 120.00 | 1.72 | 1.72 | 25.92 |
| Q4 2011 | 120.00 | 1.75 | 1.75 | 26.50 |
| Q1 2012 | 120.00 | 1.84 | 1.84 | 30.26 |
| Q2 2012 | 120.00 | 2.09 | 2.09 | 25.75 |
| Q3 2012 | 120.00 | 2.11 | 2.11 | 26.24 |
| Q4 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
| Q1 2013 | 120.00 | 1.99 | 1.99 | 27.18 |
| Q2 2013 | 120.00 | 2.19 | 2.19 | 26.14 |
| Q3 2013 | 120.00 | 2.21 | 2.21 | 27.35 |
| Q4 2013 | 120.00 | 2.23 | 2.23 | 32.18 |
| Q1 2014 | 120.00 | 2.47 | 2.47 | 32.96 |
| Q2 2014 | 120.00 | 2.33 | 2.33 | 33.21 |
| Q3 2014 | 120.00 | 2.35 | 2.35 | 35.74 |
| Q4 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
| Q1 2015 | 120.00 | 2.71 | 2.71 | 27.84 |
| Q2 2015 | 120.00 | 3.87 | 2.61 | 28.72 |
| Q3 2015 | 120.00 | 3.81 | 2.55 | 24.87 |
| Q4 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
| Q1 2016 | 120.00 | 2.89 | 2.49 | 20.84 |
| Q2 2016 | 120.00 | 1.24 | 2.10 | 20.49 |
| Q3 2016 | 120.00 | 1.03 | 1.89 | 20.40 |
| Q4 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
| Q1 2017 | 120.00 | 2.41 | 0.44 | 23.27 |
| Q2 2017 | 120.00 | 2.47 | 0.50 | 21.52 |
| Q3 2017 | 120.00 | 2.29 | 0.32 | 22.01 |
| Q4 2017 | 120.00 | 1.64 | 1.15 | 22.78 |
| Q1 2018 | 120.00 | 1.26 | 1.15 | 25.04 |
| Q2 2018 | 120.00 | 1.06 | 0.95 | 25.74 |
| Q3 2018 | 120.00 | 1.10 | 0.99 | 24.32 |
| Q4 2018 | 120.00 | 0.71 | 0.71 | 21.17 |
| Q1 2019 | 120.00 | 0.07 | 0.07 | 22.80 |
| Q2 2019 | 120.00 | (1.68) | (0.77) | 19.63 |
| Q3 2019 | 120.00 | (1.34) | (0.43) | 18.36 |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| 2009 | 101.51 | 1.53 | 1.56 | 21.46 |
| 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
| 2011 | 120.00 | 1.76 | 1.76 | 26.50 |
| 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
| 2013 | 120.00 | 2.22 | 2.22 | 32.18 |
| 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
| 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
| 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
| 2017 | 120.00 | 1.64 | 1.15 | 22.78 |
| 2018 | 120.00 | 0.64 | 0.64 | 21.17 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2010 | 16.69 | 16.04 | 0.99 |
| Q2 2010 | 14.70 | 14.15 | 1.00 |
| Q3 2010 | 14.64 | 14.10 | 0.93 |
| Q4 2010 | 15.82 | 15.53 | 0.95 |
| Q1 2011 | 17.65 | 17.65 | 1.02 |
| Q2 2011 | 15.68 | 15.68 | 0.93 |
| Q3 2011 | 14.41 | 14.41 | 0.96 |
| Q4 2011 | 15.03 | 15.03 | 0.99 |
| Q1 2012 | 17.92 | 17.92 | 1.09 |
| Q2 2012 | 12.56 | 12.56 | 1.02 |
| Q3 2012 | 13.70 | 13.70 | 1.10 |
| Q4 2012 | 14.74 | 14.74 | 1.13 |
| Q1 2013 | 13.60 | 13.60 | 1.00 |
| Q2 2013 | 15.51 | 15.51 | 1.30 |
| Q3 2013 | 15.70 | 15.70 | 1.27 |
| Q4 2013 | 19.02 | 19.02 | 1.32 |
| Q1 2014 | 19.07 | 19.07 | 1.43 |
| Q2 2014 | 19.29 | 19.29 | 1.36 |
| Q3 2014 | 21.41 | 21.41 | 1.41 |
| Q4 2014 | 12.89 | 12.89 | 1.18 |
| Q1 2015 | 14.78 | 14.78 | 1.44 |
| Q2 2015 | 11.59 | 17.18 | 1.56 |
| Q3 2015 | 9.46 | 14.14 | 1.45 |
| Q4 2015 | 11.16 | 12.29 | 1.50 |
| Q1 2016 | 11.15 | 12.96 | 1.55 |
| Q2 2016 | 29.96 | 17.69 | 1.81 |
| Q3 2016 | 30.18 | 16.49 | 1.53 |
| Q4 2016 | 17.72 | 68.63 | 1.81 |
| Q1 2017 | 15.03 | 81.82 | 1.56 |
| Q2 2017 | 14.32 | 70.59 | 1.64 |
| Q3 2017 | 14.43 | More than 100 | 1.50 |
| Q4 2017 | 18.25 | 26.14 | 1.32 |
| Q1 2018 | 24.34 | 26.70 | 1.23 |
| Q2 2018 | 30.03 | 33.56 | 1.24 |
| Q3 2018 | 28.37 | 31.57 | 1.29 |
| Q4 2018 | 41.61 | 41.61 | 1.39 |
| Q1 2019 | More than 100 | More than 100 | 1.21 |
| Q2 2019 | NEG | NEG | 1.35 |
| Q3 2019 | NEG | NEG | 1.43 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| 2009 | 15.25 | 14.94 | 1.08 |
| 2010 | 15.82 | 15.53 | 0.95 |
| 2011 | 14.95 | 14.95 | 0.99 |
| 2012 | 14.74 | 14.74 | 1.13 |
| 2013 | 19.11 | 19.11 | 1.32 |
| 2014 | 12.89 | 12.89 | 1.18 |
| 2015 | 11.16 | 12.29 | 1.50 |
| 2016 | 17.72 | 68.63 | 1.81 |
| 2017 | 18.25 | 26.14 | 1.32 |
| 2018 | 46.07 | 46.07 | 1.39 |
Q3 2019
2019
| Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
|---|---|---|---|---|---|---|---|
| Q1 2010 | - | - | - | - | 274.33 | - | - |
| Q2 2010 | - | - | - | - | 252.34 | - | - |
| Q3 2010 | - | - | - | - | 191.41 | - | - |
| Q4 2010 | - | - | - | - | 319.57 | - | - |
| Q1 2011 | - | - | - | - | 252.08 | - | - |
| Q2 2011 | - | - | - | - | 292.08 | - | - |
| Q3 2011 | - | - | - | - | 209.24 | - | - |
| Q4 2011 | - | - | - | - | 375.82 | - | - |
| Q1 2012 | - | - | - | - | 303.14 | - | - |
| Q2 2012 | - | - | - | - | 286.65 | - | - |
| Q3 2012 | - | - | - | - | 227.40 | - | - |
| Q4 2012 | - | - | - | - | 365.97 | - | - |
| Q1 2013 | - | - | - | - | 361.37 | - | - |
| Q2 2013 | - | - | - | - | 344.22 | - | - |
| Q3 2013 | - | - | - | - | 222.91 | - | - |
| Q4 2013 | - | - | - | - | 382.01 | - | - |
| Q1 2014 | - | - | - | - | 405.21 | - | - |
| Q2 2014 | - | - | - | - | 374.14 | - | - |
| Q3 2014 | - | - | - | - | 266.02 | - | - |
| Q4 2014 | - | - | - | - | 427.82 | - | - |
| Q1 2015 | - | - | - | - | 432.29 | 14.84 | - |
| Q2 2015 | - | - | - | - | 436.99 | 195.93 | - |
| Q3 2015 | - | - | - | - | 308.38 | 9.55 | - |
| Q4 2015 | - | - | - | - | 529.24 | - | - |
| Q1 2016 | - | - | - | - | 513.97 | 25.27 | - |
| Q2 2016 | - | - | - | - | 494.92 | 9.41 | - |
| Q3 2016 | - | - | - | - | 100.39 | 6.23 | - |
| Q4 2016 | - | - | - | - | 401.35 | 247.84 | - |
| Q1 2017 | - | - | - | - | 446.00 | 50.90 | (51.45) |
| Q2 2017 | - | - | - | - | 350.01 | 1.39 | (43.30) |
| Q3 2017 | - | - | - | - | 317.29 | 4.01 | (36.78) |
| Q4 2017 | - | - | - | - | 486.15 | - | (54.74) |
| Q1 2018 | - | - | - | - | 450.19 | 7.00 | (57.49) |
| Q3 2018 | 172.41 | 34.26 | 1.75 | 16.54 | - | - | - |
| Q1 2019 | 419.76 | 22.19 | 2.03 | 0.82 | - | - | - |
| Q2 2019 | 334.00 | 19.00 | 0.91 | 1.12 | - | - | - |
| Q3 2019 | 313.52 | 20.79 | 7.10 | 1.29 | - | - | - |
| Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
|---|---|---|---|---|---|---|---|
| 2009 | - | - | - | - | 950.74 | - | - |
| 2010 | - | - | - | - | 1,037.64 | - | - |
| 2011 | - | - | - | - | 1,129.22 | - | - |
| 2012 | - | - | - | - | 1,183.15 | - | - |
| 2013 | - | - | - | - | 1,310.50 | - | - |
| 2014 | - | - | - | - | 1,470.19 | - | - |
| 2015 | - | - | - | - | 1,706.80 | 115.14 | - |
| 2016 | - | - | - | - | 1,510.63 | 288.74 | (244.41) |
| 2017 | - | - | - | - | 1,599.45 | 61.92 | (186.28) |
| 2018 | 1,414.72 | 78.37 | 5.02 | 5.22 | - | - | - |
| Current | |
| Market Cap (M Riyal) | 3,744.00 |
| Enterprise Value (EV) (M) | 4,825.48 |
| Shares Outstanding ((M)) | 120.00 |
| EPS ( Riyal) (TTM) | (0.27) |
| Book Value (BV) ( Riyal) | 12.89 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | Neg |
| P/E (TTM) | NEG |
| Price/book | 2.42 |
| Return on Average Assets (%) (TTM) | (0.76 ) |
| Return on Average Equity (%) (TTM) | (2.09 ) |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}